Intensive Insulin Therapy in the Intensive Care Unit

OBJECTIVE—Hyperglycemia occurs in most critically ill patients. Using continuous glucose monitoring (CGM), we investigated whether intensive insulin therapy based on discontinuous glucose monitoring can achieve normoglycemia (80–110 mg/dl) in a medical intensive care unit (MICU). RESEARCH DESIGN AND METHODS—Fifty adults (men/women 31/19, age 62 ± 16 years, nondiabetic/diabetic 30/20, intravenous/subcutaneous insulin 22/28, and Acute Physiology and Chronic Health Evaluation II score 22 ± 7) were prospectively recruited. Forty-eight–hour CGM was performed using a subcutaneous glucose sensor (GlucoDay) and compared with arterial glycemia. Main outcome measures were percent of time in normoglycemia and accuracy/applicability of CGM. RESULTS—During 48-h CGM, glycemia reached target (80–110 mg/dl) in only 22 ± 18%, was >140 mg/dl in 39 ± 27%, and was <60 mg/dl in 5 ± 10% of the time. Patients on subcutaneous versus intravenous insulin had more glycemia readings >110 mg/dl (P = 0.016). Glycemia was higher in diabetic patients (170 ± 77 vs. 129 ± 35 mg/dl, P = 0.013). BMI was an independent determinant for bad glycemic control (β = 0.73, P < 0.0001). Diabetic state (β = 0.47, P < 0.0001), septic shock (β = 0.22, P = 0.045), sequential organ failure assessment score (β = 0.40, P = 0.001), and use of corticoids (β = 0.28, P = 0.014) and inotropics (β = −0.24, P = 0.035) were independent determinants of insulin dose. GlucoDay values and arterial glycemia correlated well (r = 0.85, P < 0.0001, n = 555 after six-point calibration), with 97% of data falling in regions A and B of error grid analysis. There were no adverse events using GlucoDay. CONCLUSIONS—GlucoDay, a well-tolerated 48-h CGM system, revealed that normoglycemia was only achieved 22% of the time in MICU patients. Further studies should investigate whether application of CGM to titrate insulin therapy can improve patient outcome.

[1]  G. Van den Berghe.  How to compare adequacy of algorithms to control blood glucose in the intensive care unit? , 2004, Critical care.

[2]  K. Butcher,et al.  Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. , 2003, Stroke.

[3]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[4]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[5]  James D Dziura,et al.  Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. , 2004, Diabetes care.

[6]  James Stephen Krinsley,et al.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.

[7]  James Stephen Krinsley,et al.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.

[8]  S. Kane-Gill,et al.  Intensive Insulin Therapy for Critically III Patients , 2004 .

[9]  F. Chee,et al.  Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time , 2003, IEEE Transactions on Information Technology in Biomedicine.

[10]  G. Van den Berghe.  How does blood glucose control with insulin save lives in intensive care? , 2004, The Journal of clinical investigation.

[11]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[12]  P. Marik,et al.  Stress-hyperglycemia, insulin and immunomodulation in sepsis , 2004, Intensive Care Medicine.

[13]  A. Kitabchi,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[14]  T. Evans,et al.  Glucose control and mortality in critically ill patients. , 2004, JAMA.

[15]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[16]  A. Aljada,et al.  The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm , 2002, Diabetologia.

[17]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[18]  J. DeVries,et al.  The use of two continuous glucose sensors during and after surgery. , 2005, Diabetes technology & therapeutics.

[19]  D. Frankenfield,et al.  Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition , 1995, Intensive Care Medicine.

[20]  F Valgimigli,et al.  A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1). , 2003, Biosensors & bioelectronics.

[21]  James D Dziura,et al.  Experience with the continuous glucose monitoring system in a medical intensive care unit. , 2004, Diabetes technology & therapeutics.

[22]  H. Gerstein,et al.  Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.

[23]  Mathijs Vogelzang,et al.  Hyperglycaemic index as a tool to assess glucose control: a retrospective study , 2004, Critical care.

[24]  M. Mlynarek,et al.  An Insulin Infusion Protocol in Critically Ill Cardiothoracic Surgery Patients , 2004, The Annals of pharmacotherapy.

[25]  B A Mizock,et al.  Alterations in carbohydrate metabolism during stress: a review of the literature. , 1995, The American journal of medicine.

[26]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[27]  Mitchell M. Levy,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[28]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.

[29]  J Hans DeVries,et al.  Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. , 2005, Diabetes care.

[30]  Boris Kovatchev,et al.  Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. , 2005, Diabetes care.

[31]  G. Grunkemeier,et al.  Glucose control lowers the risk of wound infection in diabetics after open heart operations. , 1997, The Annals of thoracic surgery.

[32]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[33]  Alberto Maran,et al.  Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. , 2002, Diabetes care.

[34]  A. Hamsten,et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.

[35]  U. Das.  Current advances in sepsis and septic shock with particular emphasis on the role of insulin. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[36]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[37]  D. Cox,et al.  Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. , 2004, Diabetes care.

[38]  Salmaan Kanji,et al.  Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults , 2004, Intensive Care Medicine.

[39]  F. Brancati,et al.  Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. , 1999, Diabetes care.